Literature DB >> 9485076

Oral collagen in the treatment of rheumatoid arthritis.

J R Kalden, J Sieper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9485076     DOI： 10.1002/1529-0131(199802)41:2<191::AID-ART2>3.0.CO;2-C

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  6 in total

Review 1.  New therapies in development for autoimmune diseases: their rationale for combination treatment.

Authors:  V Strand
Journal:  Springer Semin Immunopathol       Date:  2001

2.  In vivo evaluation of early disease progression by X-ray phase-contrast imaging in the adjuvant-induced arthritic rat.

Authors:  Yongqiang Yu; Zhuang Xiong; Yizhong Lv; Yinfeng Qian; Shiping Jiang; Yulian Tian
Journal:  Skeletal Radiol       Date:  2005-10-25       Impact factor: 2.199

3.  Synthesis of 99mTc-HYNIC-interleukin-12, a new specific radiopharmaceutical for imaging T lymphocytes.

Authors:  Alessio Annovazzi; Calogero D'Alessandria; Elena Bonanno; Stephen J Mather; Bart Cornelissen; Christophe van de Wiele; Rudi A Dierckx; Maurizio Mattei; Graziana Palmieri; Francesco Scopinaro; Alberto Signore
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-01-27       Impact factor: 9.236

4.  The biocompatible polysaccharide chitosan enhances the oral tolerance to type II collagen.

Authors:  C Porporatto; M M Canali; I D Bianco; S G Correa
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

Review 5.  The role and clinical implications of G6PI in experimental models of rheumatoid arthritis.

Authors:  Thomas Kamradt; David Schubert
Journal:  Arthritis Res Ther       Date:  2004-11-30       Impact factor: 5.156

6.  Non-NSAID over-the-counter (OTC) remedies for arthritis: good, bad or indifferent?

Authors:  M W Whitehouse; D E Butters
Journal:  Inflammopharmacology       Date:  1999       Impact factor: 5.093
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.